PlayStation is seemingly teasing news on Square Enix’s Final Fantasy VII Rebirth and the PS5-exclusive action game, Stellar Blade. Speculation is running rampant in light of a new PlayStation event, potentially another State of Play, reportedly taking place sometime this month.
As spotted by Reddit user scott1swann, the official PlayStation Twitter/X account for Germany recently began posting a series of tweets hinting at updates or news for both Final Fantasy VII Rebirth and Stellar Blade. “We hear now is the perfect time to add Final Fantasy VII Rebirth to your wishlist,” reads one tweet (translated from German), while another simply states, “Stellar Blade appears exclusively for PS5. Add the game to your wishlist now.”
READ MORE – Gotham Knights Gets ESRB Rating for Nintendo Switch
As some fans already pointed out, it would be strange of PlayStation to start promoting games without at least sharing an update via a new trailer or gameplay. Of course, these teases line up with a rumoured PlayStation event reportedly taking place this month. Sony has been relatively quiet about any major upcoming showcases but that might all change soon if the rumours are to be believed.
Final Fantasy VII Rebirth is the anticipated continuation of Final Fantasy VII Remake and the second part in a planned trilogy of remakes encompassing the original Final Fantasy VII. A new trailer for the game was shown back in June with an early 2024 release window. Fans hope that the next update will finally give us a concrete release date, especially considering that the early 2024 window is closing in.
Meanwhile, Stellar Blade also got a new trailer and 2023 release window last year during a State of Play. It was originally titled Project Eve before being rebranded as Stellar Blade and it’s touted as a new hack-and-slash action game from South Korean developer ShiftUp. It’s only a matter of time until we get a release date but with 2023 quickly coming to a close, fans fear that the game might face a delay into next year.
Source: Reddit
1 Comment